Skip to Content

Advanced Medical Solutions Group PLC AMS Stock Quote

| Rating as of

Morningstar‘s Stock Analysis AMS

Valuation
Currency in GBX
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Advanced Medical Solutions Set To Benefit As Procedure Volume Resumes; Raising Our FVE

Debbie S. Wang Senior Equity Analyst

Business Strategy and Outlook

| Debbie S. Wang |

Once solely an original equipment manufacturer for advanced wound-care products, Advanced Medical Solutions has built on its technical expertise and expanded into adjacent markets. Though AMS remains significantly smaller than Smith & Nephew, Molnlycke, and ConvaTec, we like how it has shifted its focus toward higher-margin branded surgical products and believe this strategy should enhance its already attractive returns on invested capital.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics AMS

Company Profile AMS

Business Description

U.K.-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 57% of total revenue from branded products, with nonbranded contributing 43%.

Contact
Premier Park, 33 Road One, Winsford Industrial Estate
Winsford, Cheshire, CW7 3RT, United Kingdom
T +44 1606863500
Industry Medical Instruments & Supplies
Most Recent Earnings
Fiscal Year End Dec 31, 2021
Stock Type
Employees 717